About Provecs Medical GmbH

About company

Provecs is a leading company in multi-target cancer immune gene therapy. The company has developed a well differentiated proprietary technology profile and an experienced and dedicated team to address cancer indications with unmet medical needs. Their lead program Immunalon® has been licensed to a pharma partner in one target indication. Further indications are now being qualified by a data-driven approach based on the primary tissue culture platform exviro.